Nina Capital, a Barcelona-based venture capital firm, has introduced its €50 million Fund III targeting international healthcare solutions that address specific needs. The fund will focus on clinical innovation, healthcare infrastructure, and health data, making investments between €250,000 to €1.5 million. With a goal of supporting up to 25 startups, the firm aims for a geographical spread including Europe, North America, Israel, and Australia. Fund III's backing includes significant contributions from wealth management firms and high-net-worth individuals. Nina Capital utilizes the Stanford-developed Biodesign methodology to mitigate risks in healthcare innovation, having already impacted over 10 million lives since inception.
Barcelona-based venture capital firm Nina Capital has launched its €50M Fund III to support international founders developing need-driven healthcare solutions.
Collection
[
|
...
]